Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...
China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...
Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...
ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
Experts urge policy support, remove barriers Stakeholders propose permanent API taskforce formation Local API production vital post-LDC graduation Energy, pricing hurdles threaten industry growth ...
The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle. On a quiet December 11 afternoon, entering the API ...
In drug development, the active pharmaceutical ingredient (API) is the drug component that provides the health benefits. The purpose of adding APIs is to cause pharmacological activity or direct ...
Indian drugmaker Mankind Pharma intends to add an active pharmaceutical ingredient (API) manufacturing facility to its network of 16 production plants in India. The company says it will invest about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results